Biolase Stock News

BIOLASE, Inc. (BIOL) CEO John Beaver on Q4 2021 Results - Earnings Call Transcript

Biolase (NASDAQ:BIOL) is scheduled to announce Q4 earnings results on Thursday, March 17th, after market close.The consensus EPS Estimate is -$0.03 (+57.1% Y/Y) and the consensus…

FOOTHILL RANCH, Calif., March 3, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2021 financial and operating results on Thursday, March 17, 2022 after the close of the U.S. financial…

FOOTHILL RANCH, Calif. , March 3, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2021 financi

BIOLASE Inc. (NASDAQ:BIOL) price on Thursday, February 10, rose 1.43% above its previous days close as an upside momentum from buyers pushed the stocks value to $0.43. A look at the stocks price movement, the level at last check in todays session was $0.42, moving within a range at $0.3887 and $0.42. The beta value BIOLASE Inc. (NASDAQ: BIOL) Rise 1.43%, Now What? Dont Panic Read More »

LONDON, Feb. 03, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company''s research report on the dental services market, laser dentistry is being increasingly used by dentists around the world to efficiently carry out dental procedures such as teeth whitening, tooth decay removal, gum reshaping, and lesion eradication. Laser dentistry is a technique that uses lasers to remove or alter hard and soft tissues in a variety of dental procedures. In addition to increasing the efficiency of dental procedures, laser dentistry reduces the discomfort associated with the treatment and the healing time for patients. Companies in this market, such as Apollo White Dental, Pacific Dental Services, and Great Expressions Dental, are using laser dentistry. In January 2022, Biolase Inc., a global leader in dental lasers, announced an increase in revenues in the fourth quarter of 2021. The revenue in the fourth quarter of 2021 ranged from $12.2 million to $12.5 million, up 44% to 47% over the fourth quarter of 2020 and up 20% to 23% over the fourth quarter of 2019.

BIOLASE - Speculative Buy After Strong Preliminary Q4 Results

BIOLASE <> announces preliminary Q4 Revenue in the range of $12.2M-12.5M, up 44% to 47% over Q4 2020 and 20% to 23% over Q4 2019.Company continued to gain momentum with new

Which penny stocks are you watching right now? The post Trending Penny Stocks to Watch After Holiday Season appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration.

Check these three penny stocks out for your watchlist right now The post Top Penny Stocks to Buy Now? Check These 3 Out For the New Year appeared first on Penny Stocks to Buy, Picks, News and Informat

Energy Transfer LP (NYSE:ET) with the stream of -0.85% also noticed, India BIOLASE, Inc. (NASDAQ:BIOL) encountered a rapid change of 2.49% in the last hour of Tuesdays trading session. Energy The post Foreshadowing Stock: Energy Transfer LP (NYSE:ET), BIOLASE, Inc. (NASDAQ:BIOL) appeared first on Stocks Equity .

BIOLASE (NASDAQ:BIOL) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends. Insider & Institutional Ownership 11.7% of BIOLASE shares are owned by institutional investors. 2.8% of BIOLASE shares []

Equities analysts expect BIOLASE, Inc. (NASDAQ:BIOL) to report ($0.03) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for BIOLASEs earnings. BIOLASE reported earnings per share of ($0.07) during the same quarter last year, which indicates a positive year-over-year growth rate of 57.1%. The business is scheduled to []